During the past decade, St. Luke's Brain and Stroke Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Luke's Brain and Stroke Institute" #1 sponsor was "Bristol-Myers Squibb" with 1 trials, followed by "Constantinos Hadjipanayis" with 1 trials sponsored, "Johns Hopkins University" with 1 trials sponsored, "Stryker Neurovascular" with 1 trials sponsored and "Yale University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Brain and Stroke Institute" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Emissary International LLC" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Takeda Pharmaceuticals North America, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "St. Luke's Brain and Stroke Institute" are "Diabetes" (1 trials), "Intraventricular Hemorrhage" (1 trials), "Ischemic Stroke" (1 trials), "Malignant Gliomas" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "St. Luke's Brain and Stroke Institute" in a lesser frequency.

Most popular intervention types in "St. Luke's Brain and Stroke Institute" are "Drug" (4 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Alteplase" (1 trials), "Aspirin" (1 trials), "BMS-986141" (1 trials), "Fluorescence-Guided Surgery" (1 trials) and "Gliolan®" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Brain and Stroke Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "St. Luke's Brain and Stroke Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in St. Luke's Brain and Stroke Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Brain and Stroke Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".